Carcinogen Capsules May Cause Cancer

A dangerous pill

The FDA recently discovered that certain heart and blood pressure medications contain the carcinogen NDMA, which may lead to cancer. As a result, several lawsuits have been filed against drug manufacturers and distributors, including the maker of Valsartan, Zhejiang Huahai Pharmaceutical Co.  Many of the medications have since been recalled by the FDA.  While it is reportedly difficult to prove a direct correlation between the medications and cancer, a projected 2,000 personal injury cases may be filed within the next year.  The number of cancer patients who have taken these medications that contain NDMA is unknown.

Warranted to Heal (But May Cause Cancer)

Medicinal mishap

Following the announcement of the verdict in the ongoing Johnson & Johnson baby powder case, the company’s stock shares fell 1.4%. In the Missouri joint lawsuit, 22 women claimed a direct correlation between their long-term use of Johnson & Johnson baby powder and their ovarian cancer diagnoses. A jury agreed with the evidence and testimony presented in the lawsuit and awarded $4.69 billion to the women. This compensation amount placed this lawsuit as the 6th largest product-defect verdict in the history of the US.  Johnson & Johnson is fighting back and is confident that the verdict will reverse in an appeal. 

Trouble Brewing for Starbucks

Studies have shown that up to 2 cups of black coffee per day can have a positive effect on the human body. Well, those days may be over. A non-for-profit...

Monsanto’s Weed-Killer Does Not Just Kill Weeds

Missouri-based agrochemical company, Monsanto, has for years marketed their Roundup weed-killer as both safe and non-toxic. Farmers have relied on the product to kill the harmful weeds that damage crops....

Women Seeking Relief from Menopause Get Breast Cancer

Six million women have settled with Pfizer Inc over side effects from their menopause drug Prempro. The class action lawsuit alleged that Pfizer downplayed the risk of side effects or misinformed its customers about them, leading many users of the drug to develop breast cancer.